Loading insider details...
Beta
Latest Form 4 (Jun 18, 2026): Grant/Award of 12,345 ARDX shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 18, 2026 | ARDELYX, INC. (ARDX) | Grant/Award | 12,345 | n/a |
| Aug 29, 2025 | Adaptimmune Therapeutics PLC (ADAP) | Sale | 207,000 | $2.1K |
| Jun 24, 2025 | ARDELYX, INC. (ARDX) | Grant/Award | 19,390 | n/a |
| Feb 20, 2025 | Adaptimmune Therapeutics PLC (ADAP) | Grant/Award | 1,612,032 | n/a |
| Jan 18, 2025 | Adaptimmune Therapeutics PLC (ADAP) | Sale | 5,584 | $3.2K |
| Jan 15, 2025 | Adaptimmune Therapeutics PLC (ADAP) | Sale | 4,268 | $2.5K |
| Jun 17, 2024 | ARDELYX, INC. (ARDX) | Grant/Award | 11,023 | n/a |
| Jan 17, 2024 | Adaptimmune Therapeutics PLC (ADAP) | Sale | 4,681 | $3.7K |
| Jan 17, 2024 | Adaptimmune Therapeutics PLC (ADAP) | Grant/Award | 2,544,432 | n/a |
| Jan 12, 2024 | Adaptimmune Therapeutics PLC (ADAP) | Sale | 4,009 | $3.4K |